12:00 AM
Aug 13, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

DC Bead: Phase III started

Eisai disclosed in its 1Q12 earnings that it began an open-label, Japanese Phase III trial to evaluate DC Bead in patients with hypervascularized tumors or arteriovenous malformation. Eisai has...

Read the full 123 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >